28
Participants
Start Date
May 31, 2006
Primary Completion Date
January 31, 2008
Study Completion Date
February 29, 2008
TroVax® (Immunological Vaccine Therapy)
16 Intramuscular injections of TroVax® over 47 weeks
Interferon-alpha
36 subcutaneous IFN-α injections for 12 weeks. sc injection three times per week (5MU each)
Baylor College of Medicine - Methodist Hospital, Houston
Collaborators (1)
Oxford BioMedica
INDUSTRY
The Methodist Hospital Research Institute
OTHER